Source link : https://www.newshealth.biz/health-news/bleeds-plummet-after-experimental-gene-therapy/
SAN DIEGO — Promising early results from an ongoing randomized, open-label, single-arm, Phase 3 study could pave the way for a Pfizer product to become the second US Food and Drug Administration (FDA)-approved gene therapy for hemophilia A. In an efficacy population of 50 patients with hemophilia A, the AFFINE trial found that their mean […]
Author : News Health
Publish date : 2024-12-23 12:55:27
Copyright for syndicated content belongs to the linked Source.